Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).
about
Recent advances in primary Sjogren's syndromeEULAR Sjögren's syndrome disease activity index (ESSDAI): a user guideTreatment of primary Sjögren syndrome.Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort.Characterization and risk estimate of cancer in patients with primary Sjögren syndromeReevaluation for clinical manifestations of HTLV-I-seropositive patients with Sjögren's syndrome.Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren's syndrome: results of the BELISS studySevere Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial.Characterisation of an epigenetically altered CD4(+) CD28(+) Kir(+) T cell subset in autoimmune rheumatic diseases by multiparameter flow cytometry.A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sjögren's syndrome.Incidence and Mortality of Physician-Diagnosed Primary Sjögren Syndrome: Time Trends Over a 40-Year Period in a Population-Based US Cohort.Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patientsSalivary gland ultrasonography as a predictor of clinical activity in Sjögren's syndromeEffectiveness of Traditional Chinese Medicine Compound JieDuTongLuoShengJin Granules Treatment in Primary Sjögren's Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.Safety of treatments for primary Sjögren's syndrome.Combined interventional sialendoscopy and intraductal steroid therapy for recurrent sialadenitis in Sjögren's syndrome: Results of a pilot monocentric trial.Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects.Present and future of biologic drugs in primary Sjögren's syndrome.Prevalence of Primary Sjögren's Syndrome in a US Population-Based Cohort.Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies.Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment.Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.A qualitative exploration of physical, mental and ocular fatigue in patients with primary Sjögren's Syndrome.Vitamin D Levels and Associations in Indian Patients with Primary Sjögren's Syndrome.Management of primary Sjögren's syndrome: recent developments and new classification criteria.Editorial: Rituximab in the Treatment of Sjögren's Syndrome: Is It the Right or Wrong Drug?Parameters of Somatosensory Evoked Potentials in Patients with Primary Sjӧgren's Syndrome: Preliminary Results.Anxiety and depression in primary Sjögren's syndrome: a cross-sectional study.Do the European League Against Rheumatism (EULAR) Sjögren's syndrome outcome measures correlate with impaired quality of life, fatigue, anxiety and depression in primary Sjögren's syndrome?Sjögren syndromeSjögren's syndrome: state of the art on clinical practice guidelinesWhole-volume ADC Histogram and Texture Analyses of Parotid Glands as an Image Biomarker in Evaluating Disease Activity of Primary Sjögren's Syndrome
P2860
Q26747049-6103F328-35B2-4653-8A7D-16BF410C3D23Q26778262-035C54B3-FFBB-4806-99EE-B482541D1A8DQ30249011-AE4C775A-CC88-44F6-BD06-6112B8BEF967Q31083973-F71F4D7A-735F-454E-9307-63035907E6B1Q33568158-B1305E3E-34DD-41CC-9398-CAD21C8BFFEDQ35832730-E62EC1C5-6B40-43FC-BF7C-5FA3419A0899Q36027561-F8D25720-24FF-41D3-B29A-44B46295F929Q36070691-68B6B16C-0160-44D6-9C21-789A6499780CQ36773601-47F9B558-199F-42B4-B2B9-6BB64142C10BQ38389487-4AF8EB0A-624F-425C-AD47-A6435284AA58Q38401667-33C5BC03-071B-4362-987B-BECE47DFAD63Q38633508-B0A95207-87AD-4547-A929-4F4635579CA1Q38636845-5D894BB6-CDD6-4FC8-B625-7795C8965F12Q38645543-A58F1B21-39C9-4B1F-B683-E0275494145AQ38711144-1198CCDE-D20A-4612-9CEF-E00C508DC970Q38741479-D607CD70-4961-4772-A261-6D0AD82AB964Q38795404-E17AD146-6320-4634-A2B8-7C347D399209Q38822415-0A863D5D-2454-4FA6-9362-F1CCD5C7525AQ39044724-0DF411A2-DA9A-4971-A95B-2083D3F52135Q39791068-71301291-86BF-46D0-86FE-75F655B59159Q40117123-25E5C287-DD2F-4177-8C85-0063B4BB545EQ40383414-1AA07DEC-DAA5-4C27-8811-8E1DBD102970Q46207185-1252DC4D-DC5C-4F04-A4C8-91EE83D7A92EQ47178943-242870E9-77C0-4AF8-ACCA-F277279BD2B3Q47700923-AA7768E9-D377-4133-A8D2-2CC8095EFDD4Q54384919-2EB103BE-609C-4405-8F3D-06917E587D1EQ55020926-6BC2F24D-7562-4889-AF59-0B2FB608D939Q55059469-7161CD8D-360F-4661-B8C5-DB33243A7F93Q55633625-9DEBAECD-DD12-413F-867B-97BDA3165EDBQ55970262-C750258E-0904-4527-AC81-7FF575F26344Q58602888-86C45937-9957-4306-8BD4-0BF05AE95067Q58603157-13ECC3F3-F36A-4F07-B896-35AC6B4D050C
P2860
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Defining disease activity stat ...... ent-reported indexes (ESSPRI).
@en
Defining disease activity stat ...... en's syndrome disease activity
@nl
type
label
Defining disease activity stat ...... ent-reported indexes (ESSPRI).
@en
Defining disease activity stat ...... en's syndrome disease activity
@nl
prefLabel
Defining disease activity stat ...... ent-reported indexes (ESSPRI).
@en
Defining disease activity stat ...... en's syndrome disease activity
@nl
P2093
P2860
P50
P1476
Defining disease activity stat ...... ent-reported indexes (ESSPRI).
@en
P2093
Aike A Kruize
Anne-Laure Fauchais
Athanasios Tzioufas
Claudio Vitali
Cristina Vollenweider
EULAR Sjögren's Task Force
Elke Theander
Gabriel Baron
Hendrika Bootsma
Johan G Brun
P2860
P304
P356
10.1136/ANNRHEUMDIS-2014-206008
P407
P50
P577
2014-12-05T00:00:00Z